Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by JDavenporton Nov 10, 2022 4:32pm
178 Views
Post# 35089742

RE:RE:RE:RE:RE:how do the few longs feel about jd leaving you?

RE:RE:RE:RE:RE:how do the few longs feel about jd leaving you?
I know that you haven't thought this out, 42, but it's very difficult to create and maintain specialized sites like StoxComm and jdstox. They require a lot of time and grunt work. Let's say I need revenue of $4,000 per company, per month, to maintain a site like that. Would 100 shareholders each pay the required subscription fee of $40 per month for that site? Would 200 pay $20? No, not for a penny stock. And there are good reasons why Stockhouse and Agoracom remain free.
 
And because StoxComm is so specialized with Bioasis and maybe a couple of other companies as the only companies covered, could revenue be produced by other usual internet means? I doubt it.
 
Am I interested in doing it? Not really.
 
About you calling me, so what? It's well documented that over the years I have discussed Bioasis with dozens and dozens of shareholders, the majority remaining in regular contact with me. I met a shareholder for the first time just yesterday. I spent over an hour with him and his buddy, a longtime Bioasis friend.
 
Even Bioasis IR, when they couldn't answer a question, told shareholders to "call JD." 
 
So, 42, what you think of me makes no difference to me, not when you live in the throes of a constant temper tantrum. Your biggest worry should be your own self, not me.
 
jd
<< Previous
Bullboard Posts
Next >>